PAREXEL's clinical pharmacology experts, including Board Certified medical doctors, have a broad range of therapeutic experience, including the central nervous system, cardiovascular, respiratory, metabolism/ endocrine, and oncology fields. PAREXEL's Clinical Pharmacology Research Units provide bioanalytical services, data management, biostatistics, medical writing, pharmacokinetic services, as well as consulting services for early phase clinical studies.
About PAREXEL International
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 64 locations throughout 51 countries around the world, and has more than 7,300 employees. For more information about PAREXEL International visit http://www.PAREXEL.com.
This release contains "forward-looking" statements regarding future
results and events. For this purpose, any statements contained herein that
are not statements of
|SOURCE PAREXEL International Corporation|
Copyright©2008 PR Newswire.
All rights reserved